Position in ABBV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$198,349,572
-$3,554,245 QoQ
Shares Held
911,994
+3.2% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $1,669,332,547 across 17 Drug Manufacturers - General names. ABBV ranks #5 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
503,731 | $463,316,658 | |
| 2 | JNJ |
Johnson & Johnson
|
1,054,990 | $257,881,753 | |
| 3 | AMGN |
Amgen Inc
|
643,944 | $226,571,694 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,752,898 | $210,856,097 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
911,994 | $198,349,572 | |
| 6 | AZN |
Astrazeneca PLC
|
473,389 | $93,361,776 | |
| 7 | PFE |
Pfizer Inc
|
1,984,826 | $55,733,911 | |
| 8 | NVO |
Novo Nordisk A S
|
1,433,073 | $52,665,431 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $198,349,572 | 911,994 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $201,903,817 | 883,644 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $185,757,363 | 802,269 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $141,253,291 | 760,981 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $155,439,325 | 741,883 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $135,652,091 | 763,377 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $163,884,109 | 829,877 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $139,438,897 | 812,960 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $145,398,108 | 798,452 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $115,006,954 | 742,124 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $101,138,400 | 678,508 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $84,975,288 | 630,708 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $99,524,652 | 624,488 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $103,551,444 | 640,749 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $86,195,028 | 642,240 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $77,251,758 | 504,386 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $69,647,155 | 429,629 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $57,050,518 | 421,348 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $43,678,610 | 404,919 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $39,859,352 | 353,865 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $31,612,468 | 292,113 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $28,904,353 | 269,756 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $20,066,078 | 229,091 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,693,666 | 190,402 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $12,118,169 | 159,052 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||